WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? – GeneDx Hldgs (NASDAQ:WGS), CRISPR Therapeutics (NASDAQ:CRSP), WeRide (NASDAQ:WRD)
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? WeRide…